EGCG (Epigallocatechin Gallate): Antioxidant, Metabolism, Cardiovascular & Cancer Prevention — Evidence Review
⚡ 60-Second Summary
Epigallocatechin gallate (EGCG) is the most abundant and most studied catechin in green tea (Camellia sinensis). It accounts for approximately 50–80% of total catechins in green tea leaves. EGCG's broad biological activity involves inhibiting multiple tyrosine kinases, PI3K/Akt/mTOR signaling, and VEGF receptor pathways — mechanisms that suppress cancer cell proliferation and angiogenesis while simultaneously activating antioxidant defenses through Nrf2.
Best-evidenced uses: Antioxidant status improvement (well-established); modest thermogenic/metabolic effect (meta-analyses show ~3–4% increase in energy expenditure); LDL oxidation reduction; endothelial function; cancer chemopreventive activity in multiple cancer types (human observational studies, strong preclinical evidence, early clinical trials). Best evidence is for metabolic and cardiovascular effects; cancer prevention evidence is strong but primarily observational.
Practical note: EGCG supplements have been associated with rare but serious hepatotoxicity, primarily at high doses (≥800 mg/day). This is the key safety concern distinguishing high-dose EGCG supplements from green tea beverages. Drinking green tea provides ~50–100 mg EGCG per cup — supplement doses often provide 400–800 mg, far exceeding beverage exposure. The risk appears dose-dependent; below 400 mg/day, hepatotoxicity is very rare.
What is EGCG (Epigallocatechin Gallate)?
EGCG's mechanisms include: potent antioxidant activity (scavenging reactive oxygen species and reactive nitrogen species); inhibition of DNMT1 (DNA methyltransferase), causing re-expression of silenced tumor suppressor genes; inhibition of EGFR, HER2, and VEGFR tyrosine kinases; PI3K/Akt/mTOR pathway suppression; and activation of Nrf2, which upregulates endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase).
Green tea has been consumed in China for over 3,000 years. EGCG was first isolated and characterized in the 1950s. The green tea catechin research explosion began in the 1990s with epidemiological data from Japan showing inverse correlations between green tea consumption and cancer mortality. Hundreds of in vitro and animal studies, followed by human trials, have since established EGCG as one of the most-studied natural compounds in cancer chemoprevention research.
Evidence-based benefits
1. Antioxidant status
Multiple RCTs show EGCG (400–800 mg/day) significantly increases plasma antioxidant capacity, reduces 8-isoprostane and 8-OHdG (oxidative damage markers), and decreases LDL oxidation. The antioxidant effect is dose-dependent.
2. Metabolic and thermogenic effects
Meta-analyses of >15 RCTs show green tea catechins (primarily EGCG) increase 24-hour energy expenditure by ~3–4% and fat oxidation modestly. Combined with caffeine, fat-burning effects are approximately doubled. Weight loss effect is statistically significant but clinically modest (~1–3 kg over 12 weeks).
3. Cardiovascular health
Multiple RCTs show EGCG reduces LDL cholesterol, LDL oxidation, blood pressure, and improves endothelial function (FMD). Epidemiological data from Japan associates green tea consumption with reduced cardiovascular mortality.
4. Cancer chemopreventive activity
Phase II trials show EGCG slows progression of high-grade prostate intraepithelial neoplasia, reduces colon polyp recurrence, and reduces cervical dysplasia. Observational epidemiology shows 20–50% reduced cancer risk in high green tea consumers. Preclinical evidence for anti-cancer mechanisms is extensive.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| High-EGCG green tea extract (standardized ≥45% EGCG) | 200–400 mg EGCG/day | Antioxidant, metabolic, cardiovascular | Below hepatotoxicity threshold; most daily supplementation. |
| High-dose EGCG (≥800 mg/day) | 800–1,600 mg/day | Cancer prevention protocols | Hepatotoxicity risk zone — only with medical supervision. |
| Green tea beverage (matcha, sencha) | 2–5 cups/day (~100–500 mg EGCG) | General health, antioxidant | Safest form; natural caffeine matrix; no hepatotoxicity at beverage doses. |
| Decaffeinated green tea extract | Same EGCG content, less caffeine | Caffeine-sensitive users | Retains EGCG; reduced stimulant effects. |
How much should you take?
- General supplementation: 200–400 mg EGCG/day from standardized extract
- Limit to <800 mg/day to minimize hepatotoxicity risk
- Green tea beverages: 3–5 cups/day is safe and effective for general health
Do not exceed 800 mg EGCG/day. If taking higher doses (cancer prevention protocols), do so with physician monitoring of liver enzymes. Take EGCG with food to reduce GI irritation and possible liver toxicity. People with liver disease should use caution even at lower doses. Monitor for signs of liver damage: jaundice, dark urine, abdominal pain, fatigue.
Safety and side effects
Common side effects
- GI irritation, nausea (especially on empty stomach)
- Hepatotoxicity at high doses (≥800 mg/day) — case reports of serious liver injury; rare but documented
- Caffeine-related effects if non-decaffeinated extract is used (anxiety, insomnia, palpitations)
- Iron absorption inhibition — take 2 hours away from iron supplements or iron-rich meals
Serious risks
The critical safety issue with EGCG supplements is dose-dependent hepatotoxicity. European and US regulatory agencies (EFSA, USP) have issued safety advisories. Below 400 mg/day EGCG, risk is very low. Above 800 mg/day, hepatotoxicity risk increases substantially. People with liver disease should avoid high-dose EGCG supplements. Green tea beverages at 3–5 cups/day are safe indefinitely.
Drug and nutrient interactions
- Anticoagulants (warfarin) — EGCG contains vitamin K and has antiplatelet effects; monitor INR; take separately
- Iron supplements — catechins bind non-heme iron; take 2+ hours apart
- Bortezomib (cancer drug) — EGCG directly inhibits this proteasome inhibitor; do not combine
- Stimulant medications — if EGCG extract contains caffeine, additive stimulant effects
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| People seeking evidence-based antioxidant supplementation from plant sources | People with liver disease — hepatotoxicity risk even at lower doses |
| Individuals with metabolic syndrome or weight management concerns | Those using bortezomib for cancer — direct drug interaction |
| People with cardiovascular risk factors wanting dietary polyphenol support | Pregnant or breastfeeding women — EGCG can inhibit folate metabolism and crosses placenta; limit intake |
| Those with cancer risk reduction goals (with physician guidance on dose) | People taking iron supplements — take 2+ hours apart to avoid absorption interference |
Frequently asked questions
Is EGCG safe?
At green tea beverage doses (3–5 cups/day, ~100–500 mg EGCG), EGCG is safe for most healthy adults. EGCG supplements can cause liver toxicity at high doses (≥800 mg/day) — a concern not present with beverage consumption. If supplementing, stay below 400–800 mg/day EGCG and take with food. Stop and see a doctor if you develop jaundice, dark urine, or abdominal pain.
Is green tea extract the same as EGCG?
Green tea extract contains EGCG plus other catechins (ECG, EGC, EC), caffeine, and other polyphenols. EGCG is typically 50–80% of the total catechins in green tea extract. Supplements standardized to 'green tea catechins' typically disclose EGCG percentage — confirm EGCG content, not just total catechin weight, since EGCG is the most bioactive.
Can EGCG burn fat?
Yes, modestly. Meta-analyses show green tea catechins (primarily EGCG + caffeine) increase 24-hour energy expenditure by 3–4% and fat oxidation. Over 12 weeks, this translates to approximately 1–3 kg more weight loss than placebo in controlled trials. The effect is enhanced by the natural caffeine in green tea extracts. EGCG alone without caffeine has smaller effects.
Can EGCG prevent cancer?
Epidemiological studies from Japan associate high green tea consumption with 20–50% reduced risk of several cancers (prostate, breast, colon). Phase II clinical trials show EGCG slows progression of precancerous lesions. EGCG is one of the most studied chemopreventive natural compounds. However, cancer prevention is not the same as cancer treatment, and high-dose EGCG supplements carry hepatotoxicity risk that regular green tea does not.
How does EGCG compare to green tea?
Three to five cups of green tea provide 100–500 mg EGCG with additional catechins, L-theanine, and other polyphenols in a matrix that is safe indefinitely. EGCG supplements concentrate this dramatically — a single capsule may provide as much EGCG as 8–16 cups of tea. This concentration provides therapeutic benefits but also creates hepatotoxicity risk not present in beverage form. For daily antioxidant and metabolic support, green tea or matcha may be preferable to high-dose supplements.
Related ingredients
Green Tea Extract
Full spectrum catechin supplement with EGCG plus other catechins and polyphenols.
Quercetin
Complementary plant polyphenol with anti-inflammatory and antiviral activity.
Resveratrol
Another polyphenol antioxidant with cancer prevention and cardiovascular evidence.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.